000			02269 a2200613 4500
005			20250513090550.0
264		0	_c19960626
008			199606s 0 0 eng d
022			_a0340-7004
024	7		_a10.1007/s002620050247 _2doi
040			_aNLM _beng _cNLM
100	1		_aVervoordeldonk, S F
245	0	0	_aDegradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cJan 1996
300			_a24-30 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xmetabolism
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, CD19 _ximmunology
650	0	4	_aAntigens, Differentiation, B-Lymphocyte _ximmunology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aBiological Transport _xdrug effects
650	0	4	_aBurkitt Lymphoma _xradiotherapy
650	0	4	_aCalcium Channel Blockers _xpharmacology
650	0	4	_aCell Adhesion Molecules
650	0	4	_aChloroquine _xpharmacology
650	0	4	_aColchicine _xpharmacology
650	0	4	_aEtoposide _xpharmacology
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Isotypes _xmetabolism
650	0	4	_aImmunotoxins _xmetabolism
650	0	4	_aIodine Radioisotopes
650	0	4	_aLectins
650	0	4	_aLeukemia, B-Cell _xradiotherapy
650	0	4	_aMice
650	0	4	_aMonensin _xpharmacology
650	0	4	_aPaclitaxel _xpharmacology
650	0	4	_aRadioimmunotherapy
650	0	4	_aReceptors, IgG _xdrug effects
650	0	4	_aSialic Acid Binding Ig-like Lectin 2
650	0	4	_aVerapamil _xpharmacology
650	0	4	_aVinblastine _xpharmacology
650	0	4	_aVincristine _xpharmacology
700	1		_aBalkenende, A Y
700	1		_avan den Berg, H
700	1		_avon dem Borne, A E
700	1		_avan der Schoot, C E
700	1		_aVan Leeuwen, E F
700	1		_aSlaper-Cortenbach, I C
773	0		_tCancer immunology, immunotherapy : CII _gvol. 42 _gno. 1 _gp. 24-30
856	4	0	_uhttps://doi.org/10.1007/s002620050247 _zAvailable from publisher's website
999			_c8624408 _d8624408